Evofem Biosciences Posts $2.63 Million in Q2 2026 Net Product Sales

Your call?🐂 Bullish🐻 Bearish

The company recorded an $11.144 million net loss attributable to common stockholders and a $0.08 loss per basic and diluted share. Management said cash and cash equivalents were insufficient to fund operations for at …